Example: Heart Attack

Clinical Trials Sponsored by Favrille

Total 6 results

NCT00041730

Unknown status

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Conditions: Non-Hodgkin's Lymphoma
NCT00036426

Unknown status

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Conditions: Lymphoma, Low-Grade
NCT00324831

Suspended

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Conditions: Lymphoma
NCT00258336

Unknown status

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00104819

Terminated

Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00089115

Terminated

Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Conditions: Lymphoma